Cargando…

Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy

SIMPLE SUMMARY: Natural Killer cells have shown promise to treat different malignancies. Several methods have been described to obtain fully activated NK cells for clinical use. Here, we use different cell culture media and different artificial antigen presenting cells to optimize a GMP compliant ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández, Adrián, Navarro-Zapata, Alfonso, Escudero, Adela, Matamala, Nerea, Ruz-Caracuel, Beatriz, Mirones, Isabel, Pernas, Alicia, Cobo, Marta, Casado, Gema, Lanzarot, Diego, Rodríguez-Antolín, Carlos, Vela, María, Ferreras, Cristina, Mestre, Carmen, Viejo, Aurora, Leivas, Alejandra, Martínez, Joaquín, Fernández, Lucía, Pérez-Martínez, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867223/ https://www.ncbi.nlm.nih.gov/pubmed/33540698 http://dx.doi.org/10.3390/cancers13030577

Ejemplares similares

GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
por: Fernández, Lucía, et al.
Publicado: (2019)

NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
por: Ibáñez-Navarro, Marta, et al.
Publicado: (2023)

Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells
por: Mestre-Durán, Carmen, et al.
Publicado: (2023)

Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine
por: Galán-Gómez, Víctor, et al.
Publicado: (2022)

Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19
por: García-Ríos, Estéfani, et al.
Publicado: (2022)

P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.
por: Durán, C., et al.
Publicado: (2022)

NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences
por: Perez-Luz, Sara, et al.
Publicado: (2023)

Overcoming tumor resistance mechanisms in CAR-NK cell therapy
por: Valeri, Antonio, et al.
Publicado: (2022)

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
por: Muñoz Builes, Mario, et al.
Publicado: (2020)

Ionomycin Treatment Renders NK Cells Hyporesponsive
por: Romera-Cárdenas, Gema, et al.
Publicado: (2016)

Stroke secondary to leptomeningeal carcinomatosis with radiologic signs of arterial invasion
por: Gutiérrez, María López, et al.
Publicado: (2022)

NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation
por: García-Cuesta, Eva María, et al.
Publicado: (2015)

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
por: García-García, I., et al.
Publicado: (2021)

Acid Sphingomyelinase Deficiency Type B Patient-Derived Liver Organoids Reveals Altered Lysosomal Gene Expression and Lipid Homeostasis
por: Gomez-Mariano, Gema, et al.
Publicado: (2023)

Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy
por: Vela, Maria, et al.
Publicado: (2019)

Identification of Novel Short C-Terminal Transcripts of Human SERPINA1 Gene
por: Matamala, Nerea, et al.
Publicado: (2017)

S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
por: Encinas, Jessica, et al.
Publicado: (2023)

Innovation in online food delivery: Learnings from COVID-19
por: Gavilan, Diana, et al.
Publicado: (2021)

Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
por: Herrera, Lara, et al.
Publicado: (2021)

Evaluation and Optimization of Poly-d-Lysine as a Non-Natural Cationic Polypeptide for Gene Transfer in Neuroblastoma Cells
por: Sanchez-Martos, Miguel, et al.
Publicado: (2021)

Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function
por: Vo, Dang-Nghiem, et al.
Publicado: (2020)

Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease
por: Gómez-Mariano, Gema, et al.
Publicado: (2019)

Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
por: Leivas, Alejandra, et al.
Publicado: (2016)

Donor selection for adoptive cell therapy with CD45RA(−) memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release
por: Al-Akioui-Sanz, Karima, et al.
Publicado: (2023)

SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
por: Ferreras, C., et al.
Publicado: (2021)

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses
por: Dosil, Sara G, et al.
Publicado: (2022)

Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice
por: Bai, Zongke, et al.
Publicado: (2022)

Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data
por: Ferreras-Antolin, Laura, et al.
Publicado: (2022)

EBV and the Pathogenesis of NK/T Cell Lymphoma
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2021)

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies
por: Krug, Adrien, et al.
Publicado: (2021)

Denervated muscle extract promotes recovery of muscle atrophy through activation of satellite cells. An experimental study
por: Agüera, Eduardo, et al.
Publicado: (2019)

Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms
por: Lázaro-Díez, María, et al.
Publicado: (2016)

Why do some adults with PiMZ α(1)-antitrypsin develop bronchiectasis?
por: Aggarwal, Nupur, et al.
Publicado: (2016)

Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency
por: Matamala, Nerea, et al.
Publicado: (2015)

Physiological and geometrical effects in the upper airways with and without mandibular advance device for sleep apnea treatment
por: Martínez, Adela, et al.
Publicado: (2020)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
por: Meazza, Raffaella, et al.
Publicado: (2023)

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer
por: Mendiola, Marta, et al.
Publicado: (2023)

Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas
por: Araujo-Castro, Marta, et al.
Publicado: (2020)

Impacts and Implications for Advancing in Environmental Knowledge in Hospitality Industry in COVID Society: a Bibliometric Analysis
por: Martínez-Martínez, Aurora, et al.
Publicado: (2022)

Reacciones adversas asociadas a la vacunación en pacientes inmunodeprimidos y en situaciones especiales de una Unidad de Vacunas hospitalaria
por: Fernández-Prada, María, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lq2fm1eala4lp8gacaatghr8s6